Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone

@article{Vzquez2005LowerMA,
  title={Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone},
  author={Elisa Garc{\'i}a V{\'a}zquez and Josep Maria Mensa and Jos{\'e} Antonio Mart{\'i}nez and Mar{\'i}a Marcos and Jordi Puig and Mar Ortega and Arturo Cedillo Torres},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  year={2005},
  volume={24},
  pages={190-195}
}
A cohort of 1,391 patients with community-acquired pneumonia of unknown etiology, atypical pneumonia, Legionella pneumophila pneumonia, viral pneumonia, or pneumococcal pneumonia was studied according to a standard protocol to analyse whether the addition of a macrolide to β-lactam empirical treatment decreases mortality rates. Patients admitted to the… CONTINUE READING